{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:51:21Z","timestamp":1760784681259,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["UM1 CA186107","UM1 CA176726","CA175080","CA124865","CA131332","R01 CA67262","P01 CA87969","R01 CA49449"],"award-info":[{"award-number":["UM1 CA186107","UM1 CA176726","CA175080","CA124865","CA131332","R01 CA67262","P01 CA87969","R01 CA49449"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000142","name":"Avon Foundation for Women","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10552-019-01201-2","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T15:02:42Z","timestamp":1561993362000},"page":"943-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Circulating lipids, mammographic density, and risk of breast cancer in the Nurses\u2019 Health Study and Nurses\u2019 Health Study II"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5904-2844","authenticated-orcid":false,"given":"Sarah A.","family":"Lucht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Heather","family":"Eliassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A.","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Ahern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Signe","family":"Borgquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"1201_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/bcr1829","volume":"9","author":"CM Vachon","year":"2007","unstructured":"Vachon CM, van Gils CH, Sellers TA et al (2007) Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9:217. https:\/\/doi.org\/10.1186\/bcr1829","journal-title":"Breast Cancer Res"},{"key":"1201_CR2","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1200\/JCO.2009.26.4770","volume":"28","author":"K Kerlikowske","year":"2010","unstructured":"Kerlikowske K, Cook AJ, Buist DSM et al (2010) Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol 28:3830\u20133837. https:\/\/doi.org\/10.1200\/JCO.2009.26.4770","journal-title":"J Clin Oncol"},{"key":"1201_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2214\/AJR.10.6049","volume":"198","author":"CM Checka","year":"2012","unstructured":"Checka CM, Chun JE, Schnabel FR et al (2012) The relationship of mammographic density and age: implications for breast cancer screening. Am J Roentgenol 198:134\u2013139. https:\/\/doi.org\/10.2214\/AJR.10.6049","journal-title":"Am J Roentgenol"},{"key":"1201_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju078","author":"A Pettersson","year":"2014","unstructured":"Pettersson A, Graff RE, Ursin G et al (2014) Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju078","journal-title":"J Natl Cancer Inst"},{"key":"1201_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/00001648-199211000-00011","volume":"3","author":"D Trichopoulos","year":"1992","unstructured":"Trichopoulos D, Lipman RD (1992) Mammary gland mass and breast cancer risk. Epidemiology 3:523\u2013526","journal-title":"Epidemiology"},{"key":"1201_CR6","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1158\/1055-9965.EPI-04-0920","volume":"14","author":"EJ Aiello","year":"2005","unstructured":"Aiello EJ, Tworoger SS, Yasui Y et al (2005) Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomark Prev 14:1411\u20131417","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1201_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1158\/1940-6207.CAPR-14-0267","volume":"8","author":"VG Flote","year":"2015","unstructured":"Flote VG, Frydenberg H, Ursin G et al (2015) High-density lipoprotein-cholesterol, daily estradiol and progesterone, and mammographic density phenotypes in premenopausal women. Cancer Prev Res 8:535\u2013544. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-14-0267","journal-title":"Cancer Prev Res"},{"key":"1201_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2188\/jea.JE20100078","volume":"21","author":"J Sung","year":"2011","unstructured":"Sung J, Song Y-M, Stone J et al (2011) High-density lipoprotein cholesterol, obesity, and mammographic density in Korean women: the Healthy Twin study. J Epidemiol 21:52\u201360. https:\/\/doi.org\/10.2188\/jea.JE20100078","journal-title":"J Epidemiol"},{"key":"1201_CR9","first-page":"727","volume":"4","author":"NF Boyd","year":"1995","unstructured":"Boyd NF, Connelly P, Byng J et al (1995) Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomark Prev 4:727\u2013733","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1201_CR10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0960-0760(92)90307-5","volume":"43","author":"I Hanukoglu","year":"1992","unstructured":"Hanukoglu I (1992) Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis. J Steroid Biochem Mol Biol 43:779\u2013804. https:\/\/doi.org\/10.1016\/0960-0760(92)90307-5","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1201_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1055-9965.33.14.1","volume":"14","author":"A Furberg","year":"2005","unstructured":"Furberg A, Jasienska G, Bjurstam N et al (2005) Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomark Prev 14:33\u201340","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1201_CR12","doi-asserted-by":"publisher","first-page":"djx001","DOI":"10.1093\/jnci\/djx001","volume":"109","author":"C Byrne","year":"2017","unstructured":"Byrne C, Ursin G, Martin CF et al (2017) Mammographic density change with estrogen and progestin therapy and breast cancer risk. JNCI J Natl Cancer Inst 109:djx001. https:\/\/doi.org\/10.1093\/jnci\/djx001","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1201_CR13","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/jnci\/djm062","volume":"99","author":"RM Tamimi","year":"2007","unstructured":"Tamimi RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99:1178\u20131187. https:\/\/doi.org\/10.1093\/jnci\/djm062","journal-title":"J Natl Cancer Inst"},{"key":"1201_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/oxfordjournals.aje.a115521","volume":"3","author":"L Cowan","year":"1990","unstructured":"Cowan L, O\u2019Connell D, Criqui M et al (1990) Cancer mortality and lipid and lipoprotein levels: the lipid research clinics program mortality follow-up study. Am J Epidemiol 3:468\u2013482","journal-title":"Am J Epidemiol"},{"key":"1201_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djv032","volume":"107","author":"LJ Martin","year":"2015","unstructured":"Martin LJ, Melnichouk O, Huszti E et al (2015) Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points. J Natl Cancer Inst 107:1\u20139. https:\/\/doi.org\/10.1093\/jnci\/djv032","journal-title":"J Natl Cancer Inst"},{"key":"1201_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10654-014-9884-5","volume":"29","author":"M His","year":"2014","unstructured":"His M, Zelek L, Deschasaux M et al (2014) Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur J Epidemiol 29:119\u2013132. https:\/\/doi.org\/10.1007\/s10654-014-9884-5","journal-title":"Eur J Epidemiol"},{"key":"1201_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1385\/ENDO:26:1:019","volume":"26","author":"C Han","year":"2005","unstructured":"Han C, Zhang H-T, Du L et al (2005) Serum levels of leptin, insulin, and lipids in relation to breast cancer in China. Endocrine 26:19\u201324. https:\/\/doi.org\/10.1385\/ENDO:26:1:019","journal-title":"Endocrine"},{"key":"1201_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/BF00051352","volume":"3","author":"AP H\u00f8yer","year":"1992","unstructured":"H\u00f8yer AP, Engholm G (1992) Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women. Cancer Causes Control 3:403\u2013408. https:\/\/doi.org\/10.1007\/BF00051352","journal-title":"Cancer Causes Control"},{"key":"1201_CR19","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1001\/archinte.165.19.2264","volume":"165","author":"AH Eliassen","year":"2005","unstructured":"Eliassen AH, Colditz GA, Rosner B et al (2005) Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med 165:2264\u20132271","journal-title":"Arch Intern Med"},{"key":"1201_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10549-012-2240-0","volume":"136","author":"KA Bertrand","year":"2012","unstructured":"Bertrand KA, Eliassen AH, Hankinson SE et al (2012) Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women. Breast Cancer Res Treat 136:277\u2013287. https:\/\/doi.org\/10.1007\/s10549-012-2240-0","journal-title":"Breast Cancer Res Treat"},{"key":"1201_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1158\/1055-9965.EPI-13-0907","volume":"23","author":"RE Graff","year":"2014","unstructured":"Graff RE, Cho E, Lindstrom S et al (2014) Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses\u2019 health study II. Cancer Epidemiol Biomark Prev 23:516\u2013524. https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-0907","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1201_CR22","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1158\/1055-9965.EPI-04-0722","volume":"14","author":"ER Bertone-Johnson","year":"2005","unstructured":"Bertone-Johnson ER, Chen WY, Holick MF et al (2005) Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Bioiomark Prev 14:1991\u20131997. https:\/\/doi.org\/10.1158\/1055-9965.EPI-04-0722","journal-title":"Cancer Epidemiol Bioiomark Prev"},{"key":"1201_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2337\/db11-1254","volume":"61","author":"Q Qi","year":"2012","unstructured":"Qi Q, Liang L, Doria A et al (2012) Genetic predisposition to dyslipidemia and type 2 diabetes risk in two prospective cohorts. Diabetes 61:745\u2013752. https:\/\/doi.org\/10.2337\/db11-1254","journal-title":"Diabetes"},{"key":"1201_CR24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","volume":"20","author":"CC Allain","year":"1974","unstructured":"Allain CC, Poon LS, Chan CSG et al (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470\u2013475","journal-title":"Clin Chem"},{"key":"1201_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/aje\/kwm348","volume":"167","author":"B Rosner","year":"2008","unstructured":"Rosner B, Cook N, Portman R et al (2008) Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol 167:653\u2013666. https:\/\/doi.org\/10.1093\/aje\/kwm348","journal-title":"Am J Epidemiol"},{"key":"1201_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrc1608","volume":"5","author":"GA Colditz","year":"2005","unstructured":"Colditz GA, Hankinson SE (2005) The Nurses\u2019 Health Study: lifestyle and health among women. Nat Rev Cancer 5:388\u2013396. https:\/\/doi.org\/10.1038\/nrc1608","journal-title":"Nat Rev Cancer"},{"key":"1201_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00008469-199610000-00003","volume":"5","author":"JW Byng","year":"1996","unstructured":"Byng JW, Boyd NF, Little L et al (1996) Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev 5:319\u2013327","journal-title":"Eur J Cancer Prev"},{"key":"1201_CR28","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1158\/0008-5472.CAN-09-0280","volume":"69","author":"K Walker","year":"2009","unstructured":"Walker K, Fletcher O, Johnson N et al (2009) Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res 69:6490\u20136499. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-0280","journal-title":"Cancer Res"},{"key":"1201_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/bcr1831","volume":"10","author":"LJ Martin","year":"2008","unstructured":"Martin LJ, Boyd NF (2008) Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 10:201. https:\/\/doi.org\/10.1186\/bcr1831","journal-title":"Breast Cancer Res"},{"key":"1201_CR30","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/1055-9965.EPI-05-0824","volume":"14","author":"G Haars","year":"2005","unstructured":"Haars G, Van Noord PAH, Van Gils CH et al (2005) Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomark Prev 14:2634\u20132640. https:\/\/doi.org\/10.1158\/1055-9965.EPI-05-0824","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1201_CR31","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/aje\/kwp313","volume":"170","author":"J Stone","year":"2009","unstructured":"Stone J, Warren RML, Pinney E et al (2009) Determinants of percentage and area measures of mammographic density. Am J Epidemiol 170:1571\u20131578. https:\/\/doi.org\/10.1093\/aje\/kwp313","journal-title":"Am J Epidemiol"},{"key":"1201_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87489","author":"YY Wang","year":"2017","unstructured":"Wang YY, Attan\u00e9 C, Milhas D et al (2017) Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.87489","journal-title":"JCI Insight"},{"key":"1201_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2217\/clp.14.53","volume":"9","author":"W-R Lee","year":"2014","unstructured":"Lee W-R, Ishikawa T, Umetani M (2014) The interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol. Clin Lipidol 9:617\u2013624. https:\/\/doi.org\/10.2217\/clp.14.53","journal-title":"Clin Lipidol"},{"key":"1201_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/01.ATV.0000154486.03017.35","volume":"25","author":"SI Kawachi","year":"2005","unstructured":"Kawachi SI, Takeda N, Sasaki A et al (2005) Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis. Arterioscler Thromb Vasc Biol 25:617\u2013621. https:\/\/doi.org\/10.1161\/01.ATV.0000154486.03017.35","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1201_CR35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1158\/1055-9965.EPI-06-0642","volume":"16","author":"M Verheus","year":"2007","unstructured":"Verheus M, Peeters PHM, Kaaks R et al (2007) Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomark Prev 16:451\u2013457. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0642","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1201_CR36","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/jnci\/dji279","volume":"97","author":"A McTiernan","year":"2005","unstructured":"McTiernan A, Martin CF, Peck JD et al (2005) Estrogen-plus-progestin use and mammographic density in postmenopausal women: women\u2019s health initiative randomized trial. J Natl Cancer Inst 97:1366\u20131376. https:\/\/doi.org\/10.1093\/jnci\/dji279","journal-title":"J Natl Cancer Inst"},{"key":"1201_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12885-015-1457-9","volume":"15","author":"I Skarping","year":"2015","unstructured":"Skarping I, Brand JS, Hall P, Borgquist S (2015) Effects of statin use on volumetric mammographic density: results from the KARMA study. BMC Cancer 15:435. https:\/\/doi.org\/10.1186\/s12885-015-1457-9","journal-title":"BMC Cancer"},{"key":"1201_CR38","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1002\/ijc.30013","volume":"138","author":"S Borgquist","year":"2016","unstructured":"Borgquist S, Butt T, Almgren P et al (2016) Apolipoproteins, lipids and risk of cancer. Int J Cancer 138:2648\u20132656. https:\/\/doi.org\/10.1002\/ijc.30013","journal-title":"Int J Cancer"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-019-01201-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-019-01201-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-019-01201-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T16:03:32Z","timestamp":1663862612000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-019-01201-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1007\/s10552-019-01201-2","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"9 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Borgquist reports receiving consultant fees and research support from Novartis and Roche. No conflict of interest was disclosed by the other authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}